Geetha Subramaniam MD DFAPA
Addiction, Child & Adolescent Psychiatry
Physician
Join to view full profile
6270 Montrose RdNorth Bethesda, MD 20852
Phone+1 202-997-5375
Fax+1 202-525-1499
Dr. Subramaniam is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Child and Adolescent Psychiatry, 1996 - 1998
University of Missouri-Kansas City School of MedicineResidency, Psychiatry, 1989 - 1993
Government Medical College VijayanagarClass of 1987
Certifications & Licensure
KS State Medical License 1992 - 2027
MD State Medical License 1996 - 2027
WV State Medical License 1993 - 2005
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Addiction Psychiatry
- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
Publications & Presentations
PubMed
- Collaborative care intervention for risky opioid use among primary care patients: The STOP randomized clinical trial.Jennifer McNeely, Geetha A Subramaniam, Rebecca Stone, Shayna Mazel, Noa Appleton
Addiction. 2026-06-22 - Understanding the characteristics and comorbidities of primary care patients with risky opioid use: Baseline data from the multi-site "Subthreshold Opioid Use Disorder...Yasna Rostam-Abadi, Jane M Liebschutz, Geetha Subramaniam, Rebecca Stone, Noa Appleton
Journal of General Internal Medicine. 2025-09-01 - 1 citationsWhy is substance use missing from my patient's problem list? CTN research to advance screening, prevention, and treatment of substance use in primary care.Jennifer McNeely, Katharine A Bradley, Jane M Liebschutz, Geetha A Subramaniam
Journal of Substance Use and Addiction Treatment. 2025-08-08
Press Mentions
Although Their Introductions as Treatment Are Different, Two Top Medications for Opioid Addiction Are Equally EffectiveNovember 14th, 2017
Move over, Fentanyl? Stimulant Overdose Deaths Are Rising FastApril 19th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
